| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6da7ed4d5a6e834a30e98010d98b8f7b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3688 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3682 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-368 |
| filingDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916e34671c0ffea5c9506538a89cdf4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1f3c2e202540dd1f5126ef4c6bb26e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefcd2a0a1979ce9d9054172e4c272bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089be9a3786b10dead5689994774722c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fcdb79c883a3b54fefa4def4d49c66e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9aa2ed5b98ff8e8a96851dbcb46073 |
| publicationDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9433792-B2 |
| titleOfInvention |
System and method for evaluating diastolic function based on cardiogenic impedance using an implantable medical device |
| abstract |
Diastolic function is monitored within a patient based on dynamic cardiogenic impedance as measured by a pacemaker or other implantable medical device. In one example, the device uses ventricular cardiogenic impedance values to detect E-wave parameters representative of passive filling of the ventricles. Atrial cardiogenic impedance values are used to detect A-wave parameters representative of active filling of the ventricles. Diastolic function is then assessed or evaluated based on the E-wave and A-wave parameters. Various functions of the implantable device are then controlled based on the assessment of diastolic function, such as by adjusting atrioventricular delay parameters to improve diastolic function. In some examples, the detection of E- and A-wave parameters is achieved by aligning impedance signals to atrial activation, and separately to ventricular activation, during asynchronous VOO pacing or while artificially inducing a 2:1 block. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020210060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311731-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406283-B2 |
| priorityDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |